Gene Therapy in Hemophilia B: A Journey of Innovation and Impact� is a dynamic symposium hosted by leading hematology experts to investigate the evolution of gene therapy in hemophilia B, review five-year durability data from the HOPE-B trial, and share real-world clinical insights. This interactive session will also highlight a powerful patient story that brings the promise of gene therapy to life. This symposium provides an opportunity to deepen your understanding of transformative treatment approaches and explore considerations for the future for gene therapy in hemophilia B.